IONIS PHARMACEUTICALS INC - Common Stock (IONS)
CUSIP: 462222100
Q3 2020 13F Holders as of 30 Sep 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 162,643,196
- Total 13F shares
- 118,507,239
- Share change
- -1,612,954
- Total reported value
- $5,623,405,509
- Put/Call ratio
- 128%
- Price per share
- $47.45
- Number of holders
- 353
- Value change
- -$83,647,855
- Number of buys
- 146
- Number of sells
- 177
Quarterly Holders Quick Answers
What is CUSIP 462222100?
CUSIP 462222100 identifies IONS - IONIS PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 462222100:
Top shareholders of IONS - IONIS PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
13%
|
20,810,554
|
$1,226,990,000 | — | 30 Jun 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.6%
|
12,306,251
|
$725,576,000 | — | 30 Jun 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.3%
|
8,650,728
|
$510,048,000 | — | 30 Jun 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
5.3%
|
8,611,362
|
$507,726,000 | — | 30 Jun 2020 | |
| Bellevue Group AG |
13F
|
Company |
5.1%
|
8,249,873
|
$486,413,000 | — | 30 Jun 2020 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
5.1%
|
8,218,699
|
$484,575,000 | — | 30 Jun 2020 | |
| Clearbridge Investments, LLC |
13F
|
Company |
4.7%
|
7,662,224
|
$451,765,000 | — | 30 Jun 2020 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
3,590,423
|
$211,691,000 | — | 30 Jun 2020 | |
| Invesco Ltd. |
13F
|
Company |
1.4%
|
2,339,745
|
$137,951,000 | — | 30 Jun 2020 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
1.3%
|
2,166,325
|
$127,727,000 | — | 30 Jun 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.1%
|
1,752,867
|
$103,349,000 | — | 30 Jun 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.1%
|
1,732,364
|
$102,141,000 | — | 30 Jun 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.94%
|
1,533,785
|
$90,357,000 | — | 30 Jun 2020 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.89%
|
1,447,882
|
$85,368,000 | — | 30 Jun 2020 | |
| BVF INC/IL |
13F
|
Company |
0.87%
|
1,422,842
|
$83,891,000 | — | 30 Jun 2020 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.81%
|
1,315,207
|
$77,545,000 | — | 30 Jun 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.78%
|
1,262,625
|
$74,444,000 | — | 30 Jun 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.72%
|
1,171,711
|
$69,084,000 | — | 30 Jun 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.59%
|
967,449
|
$57,042,000 | — | 30 Jun 2020 | |
| NORGES BANK |
13F
|
Company |
0.54%
|
886,145
|
$52,247,000 | — | 30 Jun 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.51%
|
830,597
|
$48,972,000 | — | 30 Jun 2020 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.48%
|
785,429
|
$46,309,000 | — | 30 Jun 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.47%
|
763,778
|
$45,032,000 | — | 30 Jun 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.45%
|
740,005
|
$43,629,000 | — | 30 Jun 2020 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.44%
|
715,880
|
$42,209,000 | — | 30 Jun 2020 | |
| DOWLING & YAHNKE LLC |
13F
|
Company |
0.42%
|
675,478
|
$39,826,000 | — | 30 Jun 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.38%
|
616,469
|
$36,348,000 | — | 30 Jun 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.38%
|
610,311
|
$35,984,000 | — | 30 Jun 2020 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.37%
|
601,697
|
$35,476,000 | — | 30 Jun 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.34%
|
555,060
|
$32,726,000 | — | 30 Jun 2020 | |
| Swiss National Bank |
13F
|
Company |
0.32%
|
528,459
|
$31,158,000 | — | 30 Jun 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.32%
|
518,169
|
$30,551,000 | — | 30 Jun 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.29%
|
478,301
|
$28,200,000 | — | 30 Jun 2020 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.29%
|
464,875
|
$27,409,000 | — | 30 Jun 2020 | |
| Legal & General Group Plc |
13F
|
Company |
0.28%
|
452,943
|
$26,705,000 | — | 30 Jun 2020 | |
| Sicart Associates LLC |
13F
|
Company |
0.26%
|
419,372
|
$24,726,000 | — | 30 Jun 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.26%
|
419,071
|
$24,710,000 | — | 30 Jun 2020 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.24%
|
386,670
|
$23,370,000 | — | 30 Jun 2020 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.23%
|
374,377
|
$22,073,000 | — | 30 Jun 2020 | |
| AJO, LP |
13F
|
Company |
0.23%
|
369,381
|
$21,778,000 | — | 30 Jun 2020 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.22%
|
353,374
|
$20,835,000 | — | 30 Jun 2020 | |
| ARK Investment Management LLC |
13F
|
Company |
0.21%
|
344,131
|
$20,290,000 | — | 30 Jun 2020 | |
| ALTRINSIC GLOBAL ADVISORS LLC |
13F
|
Company |
0.21%
|
340,900
|
$20,099,000 | — | 30 Jun 2020 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.21%
|
338,640
|
$19,966,214 | — | 30 Jun 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.2%
|
322,406
|
$19,009,000 | — | 30 Jun 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.18%
|
290,676
|
$17,138,000 | — | 30 Jun 2020 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.17%
|
278,812
|
$16,439,000 | — | 30 Jun 2020 | |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. |
13F
|
Company |
0.17%
|
269,660
|
$15,899,000 | — | 30 Jun 2020 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.16%
|
258,631
|
$15,249,000 | — | 30 Jun 2020 | |
| S.c.a. Candriam |
13F
|
Individual |
0.16%
|
253,700
|
$14,959,000 | — | 30 Jun 2020 |
Institutional Holders of IONIS PHARMACEUTICALS INC - Common Stock (IONS) as of Q3 2020
As of 30 Sep 2020,
IONIS PHARMACEUTICALS INC - Common Stock (IONS) was held by
353 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
118,507,239 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Bellevue Group AG, BlackRock Inc., Clearbridge Investments, LLC, BAILLIE GIFFORD & CO, STATE STREET CORP, Invesco Ltd., and WADDELL & REED FINANCIAL INC.
This page lists
353
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
364
Q3 2020 holders
353
Holder diff
-11
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 Value $ | Q3 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.